Won Jin Ho

4.3k total citations · 1 hit paper
59 papers, 2.1k citations indexed

About

Won Jin Ho is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Won Jin Ho has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 22 papers in Immunology and 21 papers in Molecular Biology. Recurrent topics in Won Jin Ho's work include Cancer Immunotherapy and Biomarkers (20 papers), Single-cell and spatial transcriptomics (11 papers) and Immune cells in cancer (9 papers). Won Jin Ho is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Single-cell and spatial transcriptomics (11 papers) and Immune cells in cancer (9 papers). Won Jin Ho collaborates with scholars based in United States, South Korea and Cuba. Won Jin Ho's co-authors include Elizabeth M. Jaffee, Lei Zheng, Mark Yarchoan, Elana J. Fertig, Benjamin M. Wu, Daniel A. Laheru, Ludmila Danilova, Robert A. Anders, Ranee Mehra and Hyunseok Kang and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Won Jin Ho

53 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities

2020 801 citations Won Jin Ho, Elizabeth M. Jaffee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Won Jin Ho United States	18	1.3k	629	612	438	340	59	2.1k
Huaxiang Xu China	23	1.0k 0.7×	662 1.1×	735 1.2×	477 1.1×	281 0.8×	54	2.1k
Andrew L. Coveler United States	22	1.1k 0.8×	607 1.0×	481 0.8×	268 0.6×	244 0.7×	105	1.7k
Danny N. Khalil United States	14	950 0.7×	637 1.0×	410 0.7×	204 0.5×	274 0.8×	40	1.6k
Hong Ge China	16	873 0.7×	446 0.7×	630 1.0×	300 0.7×	515 1.5×	107	2.0k
Michael Saborowski Germany	16	1.1k 0.8×	378 0.6×	968 1.6×	362 0.8×	167 0.5×	26	2.1k
Dawei Chen China	24	1.5k 1.1×	554 0.9×	508 0.8×	323 0.7×	933 2.7×	91	2.4k
Antonella Argentiero Italy	23	794 0.6×	406 0.6×	596 1.0×	427 1.0×	326 1.0×	48	1.6k
Li-Chuan Chan Taiwan	17	1.2k 0.9×	779 1.2×	965 1.6×	406 0.9×	425 1.3×	27	2.1k
Max D. Wellenstein Netherlands	9	1.3k 0.9×	1.3k 2.0×	691 1.1×	394 0.9×	307 0.9×	10	2.3k
Wei Yuan China	32	882 0.7×	912 1.4×	1.2k 2.0×	558 1.3×	399 1.2×	106	2.9k

Countries citing papers authored by Won Jin Ho

Since Specialization

Citations

This map shows the geographic impact of Won Jin Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Jin Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Jin Ho more than expected).

Fields of papers citing papers by Won Jin Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won Jin Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Jin Ho. The network helps show where Won Jin Ho may publish in the future.

Co-authorship network of co-authors of Won Jin Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Won Jin Ho. A scholar is included among the top collaborators of Won Jin Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won Jin Ho. Won Jin Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Christenson, Eric S., Tri‐Long Nguyen, Soren Charmsaz, et al.. (2025). Ablating UNG activity in a mouse model inhibits colorectal cancer growth by increasing tumor immunogenicity. JCI Insight. 10(16).

Kim, Amy K., Mark Yarchoan, Marina Baretti, et al.. (2025). Safety and efficacy of combining PD-L1 and CTLA-4 blockade with transarterial chemoembolization in intermediate-stage hepatocellular carcinoma: A phase II study.. Journal of Clinical Oncology. 43(4_suppl). 609–609.

Patel, Jay, Junwen Deng, Anusha Kambala, et al.. (2024). Spatial Mass Cytometry–Based Single-Cell Imaging Reveals a Disrupted Epithelial–Immune Axis in Prurigo Nodularis. Journal of Investigative Dermatology. 144(11). 2501–2512.e4. 3 indexed citations

Grasset, Eloïse M., Atul Deshpande, Jae W. Lee, et al.. (2024). Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells. Oncogene. 43(39). 2927–2937. 2 indexed citations

Deshpande, Atul, Hanwen Wang, Haoyang Mi, et al.. (2024). Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer Research. 84(16). 2734–2748. 13 indexed citations

Mi, Haoyang, Shamilene Sivagnanam, Won Jin Ho, et al.. (2024). Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology. Briefings in Bioinformatics. 25(5). 12 indexed citations

Charmsaz, Soren, Nicole Groß, Jae W. Lee, et al.. (2024). Abstract 5306: PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma. Cancer Research. 84(6_Supplement). 5306–5306. 1 indexed citations

Alden, Stephanie, Chester Kao, Daniel Shu, et al.. (2023). Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma. Cancer Research Communications. 3(7). 1312–1317. 21 indexed citations

Sové, Richard J., et al.. (2022). Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model. Journal for ImmunoTherapy of Cancer. 10(11). e005414–e005414. 32 indexed citations

10.

Mi, Haoyang, Won Jin Ho, Mark Yarchoan, & Aleksander S. Popel. (2022). Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma. Frontiers in Immunology. 13. 892250–892250. 33 indexed citations

11.

Shin, Sarah M., Alexei Hernandez, Erin M. Coyne, et al.. (2022). CyTOF protocol for immune monitoring of solid tumors from mouse models. STAR Protocols. 4(1). 101949–101949. 4 indexed citations

12.

Davis-Marcisak, Emily F., Atul Deshpande, Genevieve Stein-O’Brien, et al.. (2021). From bench to bedside: Single-cell analysis for cancer immunotherapy. Cancer Cell. 39(8). 1062–1080. 64 indexed citations

13.

Koldobskiy, Michael A., et al.. (2021). Engineered Interleukin-15 Autocrine Signaling Invigorates Anti-CD123 CAR-NK Cells. Blood. 138(Supplement 1). 2806–2806. 4 indexed citations

14.

Wu, Annie A., Katherine M. Bever, Won Jin Ho, et al.. (2020). A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer. Clinical Cancer Research. 26(19). 5129–5139. 91 indexed citations

15.

Danilova, Ludmila, Won Jin Ho, Qingfeng Zhu, et al.. (2019). Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival. Cancer Immunology Research. 7(6). 886–895. 180 indexed citations

16.

Bock, Cathryn H., Julie J. Ruterbusch, Andreana N. Holowatyj, et al.. (2018). Renal cell carcinoma risk associated with lower intake of micronutrients. Cancer Medicine. 7(8). 4087–4097. 15 indexed citations

17.

Ho, Won Jin, et al.. (2018). A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report. Journal for ImmunoTherapy of Cancer. 6(1). 33–33. 17 indexed citations

18.

Woo, Chang Gok, Won Jin Ho, Young Soo Park, et al.. (2016). A potential pitfall in evaluating HER2 immunohistochemistry for gastric signet ring cell carcinomas. Pathology. 49(1). 38–43. 14 indexed citations

19.

Ho, Won Jin, Edward A. Pham, Christopher Ng, et al.. (2010). Incorporation of multicellular spheroids into 3‐D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Science. 101(12). 2637–2643. 97 indexed citations

20.

Pham, Edward A., Won Jin Ho, Daniel T. Kamei, & Benjamin M. Wu. (2009). Modification of the diphenylamine assay for cell quantification in three‐dimensional biodegradable polymeric scaffolds. Journal of Biomedical Materials Research Part B Applied Biomaterials. 92B(2). 499–507. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact